Eyelid Basal Cell Carcinoma: A Retrospective Study

Abstract

Original Research ArticleAim: To study epidemiological, clinical and therapeutic characteristics of eyelid basal cell carcinomas and to emphasize the interest of early diagnosis and appropriate management of this pathology. Methods: We report a retrospective study of 30 cases of eyelid basal cell carcinoma, collected between 2009 and 2019. All our patients underwent a complete ophthalmological examination, a general examination (with search for preauricular or submandibular lymphadenopathy) and a biopsy-excision of the tumor. Orbito-cerebral CT scan was requested in tumors with locoregional extension. Results: The average age was 59 years with sex ratio equal to 1. The notion of smoking was found in 48% of cases and Xeroderma Pigmentosum in 10% of cases. The tumor was located in the lower eyelid in 2/3 of the cases. Surgical treatment involved 28 cases, or 94%. Eyelid reconstruction was required in 24 cases. We noted two cases of recurrence requiring additional resection. Conclusion: Basal cell carcinoma is the most frequent malignant tumor of the eyelids. The treatment is mainly surgical. Radiotherapy is indicated for incomplete excision, neural invasion or recurrence. The prognosis essentially depends on the risk of recurrence.